Clinical Trials List
2007-09-01 - 2008-12-31
Phase II
Terminated7
-
Trial Applicant
LOTUS PHARMACEUTICAL CO., LTD.
-
Sponsor
-
Trial scale
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Bou-Yue Peng Division of Radiation Therapy
- 李飛鵬 Division of Radiation Therapy
- JENG-FONG CHIOU Division of Radiation Therapy
- Yu-Cheng Kuo Division of Radiation Therapy
- 高仲瑜 Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 陳盛裕 Division of Radiation Therapy
- Cheng-Ying Shiau Division of Radiation Therapy
- Sheng-Yu Chen Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 林進清 Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 鍾道生 Division of Radiation Therapy
- Jo-Ting Tsa Division of Radiation Therapy
- Kuan-Chou Lin Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 張國華 Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 張國華 Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
participants
-
Global
0 participants
